Industry Verticals »

All Categories

Insights »

About TMR »

Hemoglobin A1c Testing Market

Hemoglobin A1c Testing Market (Technology: Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays, Others; End User: Laboratory Testing (Commercial Laboratories, Others), Point-of-Care (POC) Testing [Hospitals, Homecare, Clinics, Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027

  • According to the latest report published by Transparency Market Research on the global hemoglobin A1c testing market for the historical year of 2017 and forecast period of 2019 to 2027, increase in the demand for point-of-care testing for the diagnosis of diabetes, high prevalence of diabetes, and launch of automated hemoglobin A1c testing analyzers are expected to boost the growth of the global hemoglobin A1c testing market during the forecast period.
  • The global hemoglobin A1c testing market was valued at ~US$ 1 Bn in 2018, and is expected to expand at a CAGR of ~9% during the forecast period.

Increase in Prevalence of Diabetes: A Key Driver

  • Diabetes is a common health condition among the geriatric population, the prevalence of which is expected to increase over the next few years. This high prevalence of diabetes is expected to drive the growth of the hemoglobin A1c testing market during the forecast period.
  • According to the National Institutes of Health, 8.5% of the people (617 million) across the world were aged 65 years or above in 2016, and this percentage is projected to increase to nearly 17% (1.6 billion) by 2050.
  • In Europe, there has been an exponential increase in the number of patients with diabetes. This can be attributed to obesity, sedentary lifestyle, and unhealthy diet among adults in the region.
  • According to the International Diabetes Federation, over 66 million people had diabetes in Europe in 2017, and the number is likely to rise to 81 million by 2045. There were 7,476,800 cases of diabetes in Germany in 2017. Furthermore, 286,000 children had diabetes in 2017, and each year, 28,600 children are diagnosed with diabetes.
  • These factors have led to the increase in healthcare expenditure, which was US$ 207 Bn in 2017, and is likely to increase to US$ 214 Bn by 2045.

Popularity of Ion-exchange High Performance Liquid Chromatography (HPLC)

  • The ion-exchange high performance liquid chromatography (HPLC) segment dominated the global hemoglobin A1c testing market in 2018, and is expected to account for the largest market share during the forecast period, as this technology is most widely used for hemoglobin A1c testing, and provides accurate HbA1c values in the presence of hemoglobin variants in case of a highly diversified population. HPLC increases the ionic strength of buffer, identifies variants, and consumes less time.
  • Most of the devices available in the market are based on HPLC, and the technology is preferred for hemoglobin A1c testing. HPLC-based hemoglobin A1c testing analyzers can also be used in point-of-care settings, along with laboratories. In December 2015, ARKRAY, Inc. launched a glucose analyzer named 'ADAMS Glucose GA-1172', and a glycohemoglobin analyzer called 'ADAMS A1c HA-8182', to determine blood sugar and hemoglobin A1c levels in patients. The glycohemoglobin analyzer ADAMS A1c HA-8182 is based on HPLC, and provides accurate results.

North America Prominent Hemoglobin A1c Testing Market

  • North America accounted for a major share of the global hemoglobin A1c testing market in 2018, followed by Europe. Increase in the number of point-of-care testing analyzers receiving approval from the Food & Drug Administration (FDA), new product launches, and rise in the adoption of newer technologies for hemoglobin A1c testing are various factors that are expected to drive the hemoglobin A1c testing market in the region.
  • In January 2019, PTS Diagnostics announced that the U.S. Food and Drug Administration (FDA) had cleared a medical device convenience kit that quantitatively measures the percent of glycated hemoglobin, total cholesterol, high-density lipoprotein, triglycerides, and glucose in whole blood.
  • In April 2014, Abbott Laboratories received FDA approval for ARCHITECT Clinical Chemistry Hemoglobin A1c (HbA1c) test to help physicians in diagnosing and monitoring diabetes.
  • In Europe, the hemoglobin A1c testing market is expected to gain traction during the forecast period. The growth of the market in the region can be attributed to the increase in prevalence of diabetes, product approvals in the European Union (EU), and availability of automated hemoglobin A1c analyzers for laboratory settings.
  • In January 2018, Abbott Laboratories received CE approval for new Alinity h-series integrated system for hematology A1c testing. New Alinity h-series has combined features of Alinity hq and Alinity hs.
  • In April 2018, Beckman Coulter obtained CE mark for its DxH 520 hematology analyzer, which is a closed-tube, 5-part differential system for small-volume labs. In April 2018, ABL9 blood analyzers won the 'IF DESIGN AWARD 2018'.
  • The hemoglobin A1c testing market in Asia Pacific is estimated to grow at a faster pace than other regions during the forecast period, due to increase in the number of laboratory testing for diabetes, presence of well-qualified healthcare staff such as diabetologists and clinicians, and growing burden of diabetes.
  • According to the International Diabetes Federation (IDF), approximately 382 million people across the globe are expected to have diabetes by 2035, and of these, 60% will live in Asia and one-third in China.

Global Hemoglobin A1c Testing Market: Competition Landscape

  • Detailed profiles of manufacturers of hemoglobin A1c testing have been provided in the report to evaluate their key product offerings, financials, business strategies, and recent developments.
  • Key players operating in the global hemoglobin A1c testing market include
    • Abbott Laboratories
    • ARKRAY, Inc.
    • Bio-Rad Laboratories, Inc.
    • Polymer Technology Systems, Inc.
    • Danaher Corporation (Beckman Coulter)
    • F. Hoffmann-La Roche Ltd.
    • Menarini Group
    • Sebia
    • Siemens Healthineers
    • Tosoh Corporation
    • Trinity Biotech plc.

Global Hemoglobin A1c Testing Market: Key Developments

Major manufacturers in the global hemoglobin A1c testing market are adopting strategies of collaborations, partnerships, geographical expansion, distribution agreements, and new product development to strengthen their product portfolios and geographic presence in the global market. Key developments in the global hemoglobin A1c testing market are:

  • In December 2018, Arkray, Inc. established the Arkray Middle East Branch in Dubai, the UAE. Lifestyle diseases are on the rise in the Middle East due to rapid economic development in recent years and changes in lifestyle. As per the International Diabetes Federation (IDF), Saudi Arabia, the United Arab Emirates (UAE), Egypt, Bahrain, and Qatar were the top five countries with highest age-adjusted diabetes in 2017.
  • In January 2017, Abbott Laboratories announced the acquisition of St. Jude Medical, Inc., a global medical devices manufacturer. In October 2017, Abbott Laboratories acquired Alere Inc., a diagnostic device and service provider.
  • In October 2018, Beckman Coulter entered into a collaboration with Johns Hopkins Medicine. In June 2018, Beckman Coulter formed a strategic collaboration with the University of California, Irvine. In August 2016, Augusta University's medical center signed a 15-year service agreement with Danaher Corporation, the parent company of Beckman Coulter, to gain access to all diagnostic products and services of Danaher.

In the global hemoglobin A1c testing market report, we have discussed individual strategies, followed by company profiles of the manufacturers of hemoglobin testing devices. The ‘competition landscape’ section is included in the global hemoglobin A1c testing market report to provide readers with a dashboard view of key players operating in the global hemoglobin A1c testing market.

Segmentation of Global Hemoglobin A1c Testing Market

TMR’s study on the global hemoglobin A1c testing market includes information divided into three sections ? by technology, by end user, and by region. Changing industry trends and other crucial market dynamics associated with these three sections of the global hemoglobin A1c testing market have been discussed in detail.

Technology

Ion-Exchange High Performance Liquid Chromatography (HPLC)

Immunoassays

Boronate Affinity Chromatography

Direct Enzymatic Assays

Others

End User

Laboratory Testing

  • Commercial Laboratories
  • Others

Point-of-Care (POC) Testing

  • Hospitals
  • Homecare
  • Clinics
  • Others

Region

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Frequently Asked Questions

What is the total market worth of hemoglobin A1c testing market?

Hemoglobin A1c testing market to reach US$ 4,117.7 Mn by 2027

What is the anticipated CAGR of the hemoglobin A1c testing market in the forecast period?

Hemoglobin A1c testing market to expand at a CAGR of ~9% from 2019 to 2027

What are the key driving factors for the growth of the hemoglobin A1c testing market?

Hemoglobin A1c testing market is driven by increase in the demand for point-of-care testing for the diagnosis of diabetes

Which is the rising prominent segment in the hemoglobin A1c testing market?

The ion-exchange high performance liquid chromatography (HPLC) segment dominated the global hemoglobin A1c testing market

Who are the key players in the hemoglobin A1c testing market?

Key players in the global hemoglobin A1c testing market include Abbott Laboratories, ARKRAY, Inc., Bio-Rad Laboratories, Inc., Polymer Technology Systems, Inc., Danaher Corporation (Beckman Coulter)

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Hemoglobin  A1c Testing Market

        3.1. Market Overview

        3.2. Introduction

        3.3. Product Definition

        3.4. Industry Evolution / Developments

    4. Overview

        4.1. Market Dynamics

            4.1.1. Drivers

            4.1.2. Restraints

            4.1.3. Opportunities

        4.2. Global Hemoglobin A1c Testing Market Analysis and Forecast, 2017–2027

    5. Key Insights

        5.1. Recent Approved Brands for HbA1c Test, 2018

        5.2. Global Hemoglobin A1c Testing Market: Regulations

        5.3. Quantitative Analysis, by Test Type

        5.4. Europe Hemoglobin A1c Testing Market Overview

    6. Global Hemoglobin  A1c Testing Market Analysis and Forecast, by Technology 

        6.1. Introduction & Definition

        6.2. Key Findings / Developments

        6.3. Global Hemoglobin  A1c Testing Market Value Forecast, by Technology, 2017–2027

            6.3.1. Ion-Exchange High Performance Liquid Chromatography (HPLC)

            6.3.2. Immunoassay

            6.3.3. Boronate Affinity Chromatography

            6.3.4. Direct Enzymatic Assay

            6.3.5. Others

        6.4. Global Hemoglobin  A1c Testing Market Attractiveness, by Technology 

    7. Global Hemoglobin  A1c Testing Market Analysis and Forecast, by End-user 

        7.1. Introduction & Definition

        7.2. Key Findings / Developments

        7.3. Global Hemoglobin  A1c Testing Market Value Forecast, by End-user, 2017–2027

            7.3.1. Laboratory Testing

                7.3.1.1. Commercial Laboratory 

                7.3.1.2. Others

            7.3.2. Point-of-Care (POC) Testing

                7.3.2.1. Hospitals

                7.3.2.2. Homecare

                7.3.2.3. Clinics

                7.3.2.4. Others

        7.4. Global Hemoglobin  A1c Testing Market Attractiveness, by End-user 

    8. Global Hemoglobin  A1c Testing Market Analysis and Forecast, by Region

        8.1. Key Findings

        8.2. Global Hemoglobin  A1c Testing Market Value Forecast, by Region

            8.2.1. North America 

            8.2.2. Europe 

            8.2.3. Asia Pacific 

            8.2.4. Latin America 

            8.2.5. Middle East & Africa 

        8.3. Global Hemoglobin  A1c Testing Market Attractiveness, by Region

    9. North America Hemoglobin  A1c Testing Market Analysis and Forecast

        9.1. Introduction

        9.2. Key Findings

        9.3. North America Hemoglobin  A1c Testing Market Value Forecast, by Technology, 2017–2027

            9.3.1. Ion-Exchange High Performance Liquid Chromatography (HPLC)

            9.3.2. Immunoassay

            9.3.3. Boronate Affinity Chromatography

            9.3.4. Direct Enzymatic Assay

            9.3.5. Others

        9.4. North America Hemoglobin  A1c Testing Market Value Forecast, by End-user, 2017–2027

            9.4.1. Laboratory Testing

                9.4.1.1. Commercial Laboratory 

                9.4.1.2. Others

            9.4.2. Point-of-Care (POC) Testing

                9.4.2.1. Hospitals

                9.4.2.2. Homecare

                9.4.2.3. Clinics

                9.4.2.4. Others

        9.5. North America Hemoglobin  A1c Testing Market Value Forecast, by Country, 2017–2027

            9.5.1. 1. U.S.

            9.5.2. Canada

        9.6. North America Hemoglobin  A1c Testing Market Attractiveness Analysis 

            9.6.1. By Technology 

            9.6.2. By End-user 

            9.6.3. By Country

    10. Europe Hemoglobin  A1c Testing Market Analysis and Forecast

        10.1. Introduction

        10.2. Key Findings

        10.3. Europe Hemoglobin  A1c Testing Market Value Forecast, by Technology, 2017–2027

            10.3.1. Ion-Exchange High Performance Liquid Chromatography (HPLC)

            10.3.2. Immunoassay

            10.3.3. Boronate Affinity Chromatography

            10.3.4. Direct Enzymatic Assay

            10.3.5. Others

        10.4. Europe Hemoglobin  A1c Testing Market Value Forecast, by End-user, 2017–2027

            10.4.1. Laboratory Testing

                10.4.1.1. Commercial Laboratory 

                10.4.1.2. Others

            10.4.2. Point-of-Care (POC) Testing

                10.4.2.1. Hospitals

                10.4.2.2. Homecare

                10.4.2.3. Clinics

                10.4.2.4. Others

        10.5. Europe Hemoglobin  A1c Testing Market Value Forecast, by Country/Sub-region, 2017–2027

            10.5.1. Germany

            10.5.2. U.K.

            10.5.3. France

            10.5.4. Spain

            10.5.5. Italy

            10.5.6. Rest of Europe

        10.6. Europe Hemoglobin  A1c Testing Market Attractiveness Analysis 

            10.6.1. By Technology 

            10.6.2. By End-user 

            10.6.3. By Country/Sub-region

    11. Asia Pacific Hemoglobin  A1c Testing Market Analysis and Forecast

        11.1. Introduction

        11.2. Key Findings

        11.3. Asia Pacific Hemoglobin  A1c Testing Market Value Forecast, by Technology, 2017–2027

            11.3.1. Ion-Exchange High Performance Liquid Chromatography (HPLC)

            11.3.2. Immunoassay

            11.3.3. Boronate Affinity Chromatography

            11.3.4. Direct Enzymatic Assay

            11.3.5. Others

        11.4. Asia Pacific Hemoglobin  A1c Testing Market Value Forecast, by End-user, 2017–2027

            11.4.1. Laboratory Testing

                11.4.1.1. Commercial Laboratory 

                11.4.1.2. Others

            11.4.2. Point-of-Care (POC) Testing

                11.4.2.1. Hospitals

                11.4.2.2. Homecare

                11.4.2.3. Clinics

                11.4.2.4. Others

        11.5. Asia Pacific Hemoglobin  A1c Testing Market Value Forecast, by Country/Sub-region, 2017–2027

            11.5.1. China

            11.5.2. Japan

            11.5.3. India

            11.5.4. Australia & New Zealand

            11.5.5. Rest of Asia Pacific

        11.6. Asia Pacific Hemoglobin  A1c Testing Market Attractiveness Analysis 

            11.6.1. By End-user 

            11.6.2. By Country/Sub-region

    12. Latin America Hemoglobin  A1c Testing Market Analysis and Forecast

        12.1. Introduction

        12.2. Key Findings

        12.3. Latin America Hemoglobin  A1c Testing Market Value Forecast, by Technology, 2017–2027

            12.3.1. Ion-Exchange High Performance Liquid Chromatography (HPLC)

            12.3.2. Immunoassay

            12.3.3. Boronate Affinity Chromatography

            12.3.4. Direct Enzymatic Assay

            12.3.5. Others

        12.4. Latin America Hemoglobin  A1c Testing Market Value Forecast, by End-user, 2017–2027

            12.4.1. Laboratory Testing

                12.4.1.1. Commercial Laboratory 

                12.4.1.2. Others

            12.4.2. Point-of-Care (POC) Testing

                12.4.2.1. Hospitals

                12.4.2.2. Homecare

                12.4.2.3. Clinics

                12.4.2.4. Others

        12.5. Latin America Hemoglobin  A1c Testing Market Value Forecast, by Country/Sub-region, 2017–2027

            12.5.1. Brazil

            12.5.2. Mexico

            12.5.3. Rest of Latin America

        12.6. Latin America Hemoglobin  A1c Testing Market Attractiveness Analysis 

            12.6.1. By Technology 

            12.6.2. By End-user 

            12.6.3. By Country/Sub-region

    13. Middle East & Africa Hemoglobin  A1c Testing Market Analysis and Forecast

        13.1. Introduction

        13.2. Key Findings

        13.3. Middle East & Africa Hemoglobin  A1c Testing Market Value Forecast, by Technology, 2017–2027

            13.3.1. Ion-Exchange High Performance Liquid Chromatography (HPLC)

            13.3.2. Immunoassay

            13.3.3. Boronate Affinity Chromatography

            13.3.4. Direct Enzymatic Assay

            13.3.5. Others

        13.4. Middle East & Africa Hemoglobin  A1c Testing Market Value Forecast, by End-user, 2017–2027

            13.4.1. Laboratory Testing

                13.4.1.1. Commercial Laboratory 

                13.4.1.2. Others

            13.4.2. Point-of-Care (POC) Testing

                13.4.2.1. Hospitals

                13.4.2.2. Homecare

                13.4.2.3. Clinics

                13.4.2.4. Others

        13.5. Market Value Forecast, by Country/Sub-region, 2017–2027

            13.5.1. GCC Countries

            13.5.2. South Africa

            13.5.3. Rest of Middle East & Africa

        13.6. Middle East & Africa Hemoglobin  A1c Testing Market Attractiveness Analysis 

            13.6.1. By Technology 

            13.6.2. By End-user 

            13.6.3. By Country/Sub-region

    14. Competition Landscape

        14.1. Market Player – Competition Matrix (By Tier and Size of companies)

        14.2. Market Share Analysis by Company (2018)

        14.3. Company Profiles

            14.3.1. Abbott Laboratories

                14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.1.2. Financial Overview

                14.3.1.3. Product Portfolio

                14.3.1.4. SWOT Analysis

                14.3.1.5. Strategic Overview

            14.3.2. ARKRAY, Inc.

                14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.2.2. Product Portfolio

                14.3.2.3. SWOT Analysis

                14.3.2.4. Strategic Overview

            14.3.3. Bio-Rad Laboratories, Inc.

                14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.3.2. Financial Overview

                14.3.3.3. Product Portfolio

                14.3.3.4. SWOT Analysis

                14.3.3.5. Strategic Overview

            14.3.4. Polymer Technology Systems, Inc.

                14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.4.2. Product Portfolio

                14.3.4.3. SWOT Analysis

                14.3.4.4. Strategic Overview

            14.3.5. Danaher Corporation (Beckman Coulter)

                14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.5.2. Financial Overview

                14.3.5.3. Product Portfolio

                14.3.5.4. SWOT Analysis

                14.3.5.5. Strategic Overview

            14.3.6. F. Hoffmann-La Roche Ltd.

                14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.6.2. Financial Overview

                14.3.6.3. Product Portfolio

                14.3.6.4. SWOT Analysis

                14.3.6.5. Strategic Overview

            14.3.7. Menarini Group

                14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.7.2. Product Portfolio

                14.3.7.3. SWOT Analysis

                14.3.7.4. Strategic Overview

            14.3.8. Sebia

                14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.8.2. Product Portfolio

                14.3.8.3. SWOT Analysis

                14.3.8.4. Strategic Overview

            14.3.9. Siemens Healthineers

                14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.9.2. Financial Overview

                14.3.9.3. Product Portfolio

                14.3.9.4. SWOT Analysis

                14.3.9.5. Strategic Overview

            14.3.10. Tosoh Corporation

                14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.10.2. Financial Overview

                14.3.10.3. Product Portfolio

                14.3.10.4. SWOT Analysis

                14.3.10.5. Strategic Overview

            14.3.11. Trinity Biotech plc.

                14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.11.2. Financial Overview

                14.3.11.3. Product Portfolio

                 14.3.11.4. SWOT Analysis

                 14.3.11.5. Strategic Overview

    List of Tables

    Table 01: Global Hemoglobin A1c Testing Market Value (US$ Mn) Forecast, by Technology, 2017–2027

    Table 02: Global Hemoglobin A1c Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2027

    Table 03: Global Hemoglobin A1c Testing Market Value (US$ Mn) Forecast, by Laboratories, 2017–2027

    Table 04: Global Hemoglobin A1c Testing Market Value (US$ Mn) Forecast, by Point-of-care (POC) Settings, 2017–2027

    Table 05: Global Hemoglobin A1c Testing Market Value (US$ Mn) Forecast, by Region, 2016–2026

    Table 06: North America Hemoglobin A1c Testing Market Value (US$ Mn) Forecast, by Country, 2017–2027

    Table 07: North America Hemoglobin A1c Testing Market Value (US$ Mn) Forecast, by Technology, 2017–2027

    Table 08: North America Hemoglobin A1c Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2027

    Table 09: North America Hemoglobin A1c Testing Market Value (US$ Mn) Forecast, by Laboratories, 2017–2027

    Table 10: North America Hemoglobin A1c Testing Market Value (US$ Mn) Forecast, by Point-of-Care (POC) Settings, 2017–2027

    Table 11: Europe Hemoglobin A1c Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    Table 12: Europe Hemoglobin A1c Testing Market Value (US$ Mn) Forecast, by Technology, 2017–2027

    Table 13: Europe Hemoglobin A1c Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2027

    Table 14: Europe Hemoglobin A1c Testing Market Value (US$ Mn) Forecast, by Laboratories, 2017–2027

    Table 15: Europe Hemoglobin A1c Testing Market Value (US$ Mn) Forecast, by Point-of-Care (POC) Settings, 2017–2027

    Table 16: Asia Pacific Hemoglobin A1c Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    Table 17: Asia Pacific Hemoglobin A1c Testing Market Value (US$ Mn) Forecast, by Technology, 2017–2027

    Table 18: Asia Pacific Hemoglobin A1c Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2027

    Table 19: Asia Pacific Hemoglobin A1c Testing Market Value (US$ Mn) Forecast, by Laboratories, 2017–2027

    Table 20: Asia Pacific Hemoglobin A1c Testing Market Value (US$ Mn) Forecast, by Point-of-Care (POC) Settings, 2017–2027

    Table 21: Latin America Hemoglobin A1c Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    Table 22: Latin America Hemoglobin A1c Testing Market Value (US$ Mn) Forecast, by Technology, 2017–2027

    Table 23: Latin America Hemoglobin A1c Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2027

    Table 24: Latin America Hemoglobin A1c Testing Market Value (US$ Mn) Forecast, by Laboratories, 2017–2027

    Table 25: Latin America Hemoglobin A1c Testing Market Value (US$ Mn) Forecast, by Point-of-Care (POC) Settings, 2017–2027

    Table 26: Middle East & Africa Hemoglobin A1c Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    Table 27: Middle East & Africa Hemoglobin A1c Testing Market Value (US$ Mn) Forecast, by Technology, 2017–2027

    Table 28: Middle East & Africa Hemoglobin A1c Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2027

    Table 29: Middle East & Africa Hemoglobin A1c Testing Market Value (US$ Mn) Forecast, by Laboratories, 2017–2027

    Table 30: Middle East & Africa Hemoglobin A1c Testing Market Value (US$ Mn) Forecast, by Point-of-Care (POC) Settings, 2017–2027

    List of Figures

    Figure 01: Global Hemoglobin A1c Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

    Figure 02: Global Market Value Share, by Technology, 2018

    Figure 03: Global Market Value Share, by Point-of-Care (POC) Settings, 2018

    Figure 04: Global Market Value Share, by End-user, 2018

    Figure 05: Global Market Value Share, by Region, 2018

    Figure 06:  Global Market Share (% ) of Laboratory Test & POC Test, 2018

    Figure 07:  Global Market Share (% ) of Laboratory Test & POC Test, 2027

    Figure 08: Global  POC based Hemoglobin A1c Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

    Figure 09: North America POC based Hemoglobin A1c Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

    Figure 10: Europe POC based Hemoglobin A1c Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

    Figure 11: Asia Pacific POC based Hemoglobin A1c Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

    Figure 12: Latin America POC based Hemoglobin A1c Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

    Figure 13: Middle East & Africa POC based Hemoglobin A1c Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

    Figure 14: Global Hemoglobin A1c Testing Market Value Share, by Technology, 2018 and 2027

    Figure 15: Global Hemoglobin A1c Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Ion-exchange HPLC, 2017–2027

    Figure 16: Global Hemoglobin A1c Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Immunoassay, 2017–2027

    Figure 17: Global Hemoglobin A1c Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Boronate Affinity Chromatography, 2017–2027

    Figure 18: Global Hemoglobin A1c Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Direct Enzymatic Assay, 2017–2027

    Figure 19: Global Hemoglobin A1c Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2017–2027

    Figure 20: Global Hemoglobin A1c Testing Market Attractiveness, by Technology, 2019–2027

    Figure 21: Global Hemoglobin A1c Testing Market Value Share, by End-user, 2018 and 2026

    Figure 22: Global Hemoglobin A1c Testing Market Attractiveness, by End-user, 2019–2027

    Figure 23: Global Hemoglobin A1c Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Laboratories, 2017–2027

    Figure 24: Global Hemoglobin A1c Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Point-of-care (POC) Settings, 2017–2027

    Figure 25: Global Hemoglobin A1c Testing Market Value Share, by Region, 2018 and 2027

    Figure 26: Global Hemoglobin A1c Testing Market Attractiveness, by Region, 2018–2026

    Figure 27: North America Hemoglobin A1c Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

    Figure 28: North America Hemoglobin A1c Testing Market Value Share, by Country, 2018–2027

    Figure 29: North America Hemoglobin A1c Testing Market Attractiveness, by Country, 2019–2027

    Figure 30: North America Hemoglobin A1c Testing Market Value Share, by Technology, 2018 and 2027

    Figure 31: North America Hemoglobin A1c Testing Market Attractiveness, by Technology, 2019–2027

    Figure 32: North America Hemoglobin A1c Testing Market Value Share, by End-user, 2018 and 2027

    Figure 33: North America Hemoglobin A1c Testing Market Attractiveness, by End-user, 2019–2027

    Figure 34: Europe Hemoglobin A1c Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

    Figure 35: Europe Hemoglobin A1c Testing Market Value Share, by Country, 2018–2027

    Figure 36: Europe Hemoglobin A1c Testing Market Attractiveness, by Country, 2019–2027

    Figure 37: Europe Hemoglobin A1c Testing Market Value Share, by Technology, 2018 and 2027

    Figure 38: Europe Hemoglobin A1c Testing Market Attractiveness, by Technology, 2019–2027

    Figure 39: Europe Hemoglobin A1c Testing Market Value Share, by End-user, 2018 and 2027

    Figure 40: Europe Hemoglobin A1c Testing Market Attractiveness, by End-user, 2019–2027

    Figure 41: Asia Pacific Hemoglobin A1c Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

    Figure 42: Asia Pacific Hemoglobin A1c Testing Market Value Share, by Country/Sub-Region, 2018 and 2027

    Figure 43: Asia Pacific Hemoglobin A1c Testing Market Attractiveness, by Country/Sub-Region, 2019–2027

    Figure 44: Asia Pacific Hemoglobin A1c Testing Market Value Share, by Technology, 2018 and 2027

    Figure 45: Asia Pacific Hemoglobin A1c Testing Market Attractiveness, by Technology, 2019–2027

    Figure 46: Asia Pacific Hemoglobin A1c Testing Market Value Share, by End-user, 2018 and 2027

    Figure 47: Asia Pacific Hemoglobin A1c Testing Market Attractiveness, by End-user, 2019–2027

    Figure 48: Latin America Hemoglobin A1c Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

    Figure 49: Latin America Hemoglobin A1c Testing Market Value Share, by Country/Sub-Region, 2018 and 2027

    Figure 50: Latin America Hemoglobin A1c Testing Market Attractiveness, by Country/Sub-region, 2019–2027

    Figure 51: Latin America Hemoglobin A1c Testing Market Value Share, by Technology, 2018 and 2027

    Figure 52: Latin America Hemoglobin A1c Testing Market Attractiveness, by Technology, 2019–2027

    Figure 53: Latin America Hemoglobin A1c Testing Market Value Share, by End-user, 2018 and 2027

    Figure 54: Latin America Hemoglobin A1c Testing Market Attractiveness, by End-user, 2019–2027

    Figure 55: Middle East & Africa Hemoglobin A1c Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

    Figure 56: Middle East & Africa Hemoglobin A1c Testing Market Value Share, by Country/Sub-region, 2018 and 2027

    Figure 57: Middle East & Africa Hemoglobin A1c Testing Market Attractiveness, by Country/Sub-region, 2019–2027

    Figure 58: Middle East & Africa Hemoglobin A1c Testing Market Value Share, by Technology, 2018 and 2027

    Figure 59: Middle East & Africa Hemoglobin A1c Testing Market Attractiveness, by Technology, 2019–2027

    Figure 60: Middle East & Africa Hemoglobin A1c Testing Market Value Share, by End-user, 2018 and 2027

    Figure 61: Middle East & Africa Hemoglobin A1c Testing Market Attractiveness, by End-user, 2019–2027

    Figure 62: Global Hemoglobin A1c Testing Market Analysis, by Top Company Ranking, 2017

    Figure 63: Tosoh Corporation Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

    Figure 64: Tosoh Corporation Research & Development Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018

    Figure 65: Tosoh Corporation Breakdown of Net Sales (% Share), by Business Segment (2018)

    Figure 66: Tosoh Corporation Breakdown of Net Sales (% Share), by Region (2018)

    Figure 67: Bio-Rad Laboratories, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2018

    Figure 68: Bio-Rad Laboratories, Inc. Breakdown of Net Sales (% Share), by Business Segment (2018)

    Figure 69: Trinity Biotech plc.  Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

    Figure 70: Trinity Biotech plc. Research & Development Expenses, 2015–2018

    Figure 71: Trinity Biotech plc. Breakdown of Net Sales (% Share), by Business Segment (2018)

    Figure 72: Trinity Biotech plc. Breakdown of Net Sales (% Share), by Region (2018)

    Figure 73: Abbott Laboratories Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

    Figure 74: Abbott Laboratories R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018

    Figure 75: Abbott Laboratories Breakdown of Net Sales (% Share), by Business Segment, 2018

    Figure 76: Abbott Laboratories Breakdown of Net Sales (% Share), by Region, 2018

    Figure 77: F. Hoffmann-La Roche Ltd. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

    Figure 78: F. Hoffmann-La Roche Ltd. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018

    Figure 79: F. Hoffmann-La Roche Ltd. Breakdown of Net Sales (% Share), by Business Segment, 2018

    Figure 80: F. Hoffmann-La Roche Ltd. Breakdown of Net Sales (% Share), by Region, 2018

    Figure 81: Danaher Corporation Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

    Figure 82: Danaher Corporation R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2017 

    Figure 83: Danaher Corporation Breakdown of Net Sales (% Share), by Business Segment, 2018

    Figure 84: Danaher Corporation Breakdown of Net Sales (% Share), by Geography, 2018

    Figure 85: Siemens Healthineers Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

    Figure 86: Siemens Healthineers Research and Development Expenses, 2015–2018

    Figure 87: Siemens Healthineers Breakdown of Net Sales (% Share), by Business Segment, 2018

    Figure 88: Siemens Healthineers Breakdown of Net Sales (% Share), by Region, 2018

Copyright © Transparency Market Research, Inc. All Rights reserved

Hemoglobin A1c Testing Market

Schedule a Call